RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Orchard Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-20 4:30 pm Purchase | 2023-03-10 | 13G | Orchard Therapeutics plc ORTX | RA CAPITAL MANAGEMENT L.P. | 18,564,300 9.990% | 18,564,300 (New Position) | Filing |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | Orchard Therapeutics plc ORTX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -969,479 (Position Closed) | Filing |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Orchard Therapeutics plc ORTX | RA CAPITAL MANAGEMENT L.P. | 969,479 7.700% | -262,042 (-21.28%) | Filing |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Orchard Therapeutics plc ORTX | RA CAPITAL MANAGEMENT L.P. | 1,231,521 12.600% | 195,056 (+18.82%) | Filing |
| 2020-04-09 4:56 pm Purchase | 2020-03-31 | 13G | Orchard Therapeutics plc ORTX | RA CAPITAL MANAGEMENT L.P. | 1,036,466 10.700% | 397,476 (+62.20%) | Filing |
| 2020-02-14 4:34 pm Purchase | 2019-12-31 | 13G | Orchard Therapeutics plc ORTX | RA CAPITAL MANAGEMENT L.P. | 638,990 6.600% | 154,397 (+31.86%) | Filing |